Molecular Cancer Research : Mcr

• 

  Publication Venue For

  • SPHK1 Is a Novel Target of Metformin in Ovarian Cancer..  17:870-881. 2019
  • Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes. 2019
  • Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition..  16:599-609. 2018
  • A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma..  15:1777-1791. 2017
  • Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG..  15:1243-1254. 2017
  • Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer..  15:1221-1229. 2017
  • CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC..  15:660-669. 2017
  • The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma..  14:344-353. 2016
  • Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma..  14:287-295. 2016
  • p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma.  13:584-591. 2015
  • Delineation of a FOXA1/ERα/AGR2 regulatory loop that is dysregulated in endocrine therapy-resistant breast cancer..  12:1829-1839. 2014
  • Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer..  12:924-939. 2014
  • Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide..  12:48-57. 2014
  • S100A14: Novel Modulator of Terminal Differentiation in Esophageal Cancer.  11:1542-1553. 2013
  • CLT1 targets bladder cancer through integrin α5β1 and CLIC3..  11:194-203. 2013
  • A message from the Editor-in-Chief..  10:1513. 2012
  • Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma..  10:208-217. 2012
  • Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells..  9:1718-1731. 2011
  • Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes..  8:232-245. 2010
  • Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis..  8:223-231. 2010
  • Hsp90 is an essential regulator of EphA2 receptor stability and signaling: implications for cancer cell migration and metastasis..  7:1021-1032. 2009
  • Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism..  7:745-754. 2009
  • Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy..  7:199-209. 2009
  • Yin yang 1 modulates taxane response in epithelial ovarian cancer..  7:210-220. 2009
  • Identification and functional characterization of the human glutathione S-transferase P1 gene as a novel transcriptional target of the p53 tumor suppressor gene..  6:843-850. 2008
  • DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture..  6:517-524. 2008
  • A message from the editor.  5. 2007
  • Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis..  5:705-711. 2007
  • Editor's note.  5. 2007
  • Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer..  4:283-292. 2006
  • A mechanism of COOH-terminal binding protein-mediated repression..  3:575-583. 2005
  • TAFII70 isoform-specific growth suppression correlates with its ability to complex with the GADD45a protein..  2:442-452. 2004
  • Chromatin association of rad17 is required for an ataxia telangiectasia and rad-related kinase-mediated S-phase checkpoint in response to low-dose ultraviolet radiation..  2:362-369. 2004
  • Molecular Cancer Research: A Note from the Editor.  1. 2003
  • Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival..  1:1036-1047. 2003
  • Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt gene of mouse fibroblasts expressing antisense RNA to DNA polymerase zeta..  1:836-847. 2003
  • Fatty acid synthase expression defines distinct molecular signatures in prostate cancer..  1:707-715. 2003
  • Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage..  1:674-681. 2003
  • Molecular markers in ductal carcinoma in situ of the breast..  1:362-375. 2003
  • Phosphorylation of the cyclin b1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx..  1:280-289. 2003
  • Welcome to molecular cancer research.  1:1. 2002